Enliven Therapeutics Inc. logo

Enliven Therapeutics Inc.

ELVN | NASDAQ
Chart Builder DCF Calculator
$48.30
-$0.57 (-1.17%)
Sep 22, 2026, 2:15 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-103.69M -89.02M -71.58M -37.66M -24.74M -18.97M
Depreciation & Amortization
263K 317K 297K 215K 115K 45K
Stock-Based Compensation
34.02M 20.17M 12.91M 3.19M 1.92M 130K
Other Working Capital
-1.94M -5.35M 3.65M 27K 1.83M 292K
Other Non-Cash Items
232K -118K -4.3M 1.74M 3.81M 9.68M
Deferred Income Tax
n/a n/a n/a n/a -3.81M n/a
Change in Working Capital
-1.12M -4.54M 1.4M 438K 3.57M 583K
Operating Cash Flow
-70.3M -73.19M -61.27M -32.08M -19.13M -8.53M
Capital Expenditures
-158K -44K -149K -612K -191K -461K
Cash Acquisitions
n/a n/a n/a 35M n/a n/a
Purchase of Investments
-446.79M -350.74M -268.26M -35M -47.56M -64.2M
Sales Maturities Of Investments
272.9M 313.91M 120M 41.88M 45.94M 47.5M
Other Investing Acitivies
213K 873K n/a -41.88M 1.62M 16.7M
Investing Cash Flow
-173.84M -36M -148.41M -612K -191K -461K
Debt Repayment
n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 93.98M 73.09M -566K n/a 33.63M
Financial Cash Flow
218.87M 133.17M 234.29M -1.8M -1.02M 130.51M
Net Cash Flow
-25.28M 23.98M 24.61M -34.49M -20.34M 121.52M
Free Cash Flow
-70.46M -73.24M -61.42M -32.69M -19.33M -8.99M
Adj. Free Cash Flow
-104.48M -93.41M -74.33M -35.88M -21.25M -9.12M
Maintenance CapEx
-158K -44K -149K -215K -115K -45K
Growth CapEx
n/a n/a n/a -397K -76K -416K
Owner Earnings
-70.46M -73.24M -61.42M -32.29M -19.25M -8.57M

© 2026 bestshares.com. All rights reserved.